Kerala HC says exorbitant drug prices can trigger government intervention in patented medicines

The Kerala High Court ruled that government intervention is permissible for prohibitively priced patented medicines. The court directed the Centre to gather data on the affordability of specific life-saving drugs. This ruling addresses access issues for two breast cancer medications, abemaciclib and ribociclib. The decision empowers the government to consider invoking Section 100 of the Patents Act for affordable access.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/kNIEnjZ
via IFTTT

Read More

Sun Pharma signs major deal with LIB Therapeutics of US, gains access to $3.7-bn global market for bad cholesterol inhibitor PCSK9

Sun Pharma has signed an exclusive agreement with LIB Therapeutics for Lerodalcibep, a cholesterol-lowering medication. This deal covers all markets globally except for the United States and China. Lerodalcibep, a once-monthly PCSK9 inhibitor, will be marketed under the name Lyrokaul in Europe.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/YrEHkSp
via IFTTT

Read More

Govt, private hospitals likely to be graded on quality & safety

Niti Aayog is developing a national quality framework for public and private hospitals, aligned with international standards, to help patients compare hospitals and improve healthcare quality. The framework will include patient safety, clinical outcomes, readmission rates, medication errors and specialty-specific indicators such as survival and mortality rates.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/dRmPYG1
via IFTTT

Read More

CDSCO steps up scrutiny of pharma drugs containing narcotic substances

The Central Drugs Standard Control Organisation is addressing regulatory gaps related to the illegal diversion of pharmaceutical drugs. Following the National Committee for Coordination on Drug Trafficking meeting, specific targets have been assigned to CDSCO. The drugs consultative committee will examine current regulations to recommend improvements. Union home minister Amit Shah emphasized the need for a coordinated strategy against evolving drug trafficking.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/y3KmoGR
via IFTTT

Read More

Fortis Healthcare confident forensic audit will clear company in share transfer dispute

Fortis Healthcare has expressed confidence that a forensic audit will verify its non-involvement in a share transfer dispute. The Supreme Court's recent ruling allows the audit to proceed while minimizing the influence of previous judgments. Fortis clarified that it was never a party to the arbitration between the Singh Brothers and Daiichi Sankyo.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/oL67Mlu
via IFTTT

Read More

Fortis defends itself after Supreme Court allows forensic audit, says it was "complete stranger" to Daiichi-Singh Brothers dispute

In a disclosure to the stock exchanges, Fortis said the Supreme Court, in its September 25 order, disposed of the company's Special Leave Petition challenging the Delhi High Court's August 31 order directing a forensic audit of the company in the matter of Daiichi Sankyo Company Limited vs. Malvinder Mohan Singh & Ors.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/kF1jaJZ
via IFTTT

Read More

Ayush services sector growing fast; projected to hit up to USD 318 billion by 2047: Study

The Ayush services sector is projected to reach USD 216-318 billion by 2047 as it continues to expand. This sector reported a 16.91 percent compound annual growth rate since 2022-23 and supported 1.76 million livelihoods. Clinics and day-care centers generated the majority of the sector's revenue, with Ayurveda leading individual systems. The sector's role in Medical Value Travel is also notable with international patients contributing substantially to revenues.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/30xLvPX
via IFTTT

Read More